Skip to content
Screener

Edgewise Therapeutics, Inc. EWTX Q2 2026 earnings

Reported August 6, 2026 · Before market open

EPS-$0.53Miss by $0.06
EPS estimate-$0.47

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$129.2M
EPS estimate-$0.55

FAQ

When did Edgewise Therapeutics, Inc. report Q2 2026 earnings?
Edgewise Therapeutics, Inc. (EWTX) reported Q2 2026 earnings on August 6, 2026 before market open.
What were Edgewise Therapeutics, Inc.'s Q2 2026 revenue and EPS?
Edgewise Therapeutics, Inc. reported eps of $-0.53 for Q2 2026.
Did Edgewise Therapeutics, Inc. beat estimates in Q2 2026?
EPS missed the consensus estimate of $-0.47 by $0.06.
How did Edgewise Therapeutics, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 55.9% from $-0.34.
Where can I find Edgewise Therapeutics, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001104659-26-091671) and the 10-Q periodic report (0001104659-26-091670) directly on SEC EDGAR. The filing index links above go to sec.gov.